#ProtagenicTherapeutics hashtag - Bluesky

@prismmarketview.bsky.social

7 months ago

Protagenic Therapeutics Moves PT00114 Forward, Eyes Key Catalysts in 2025–2026 Protagenic Therapeutics (NASDAQ: PTIX) has advanced its lead drug candidate PT00114 into the multiple-dose portion of its Phase 1 clinical trial, marking anothe

(NASDAQ: #PTIX)
#ProtagenicTherapeutics just advanced PT00114 into the multiple-dose Phase 1 trial—dosing complete by end of August & topline safety data expected September. Phase 2 could launch Q1 2026.
prismmarketview.com/protagenic-t...